Patient perceptions regarding local reactions from allergen immunotherapy injections

Annals of Allergy, Asthma and Immunology

Volumn 101, Issue 1, 2008, Pages 96-100

  Coop, Christopher A ^a,b   Tankersley, Michael S ^a  

^a WILFORD HALL MEDICAL CENTER   (United States)

^b Lackland AFB ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL PRACTICE; FEMALE; HEALTH SURVEY; HUMAN; IMMUNOTHERAPY; LOCAL SKIN REACTION; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUESTIONNAIRE;

EID: 47349125395     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60841-1     Document Type: Article

References (18)

1. Bousquet J, Lockey RF, Mailing H-J. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy. 1998;53:1-42.
2. Nelson BL, Dupont LA, Reid MJ. Prospective survey of local and systemic reactions to immunotherapy with pollen extracts. Ann Allergy. 1986;56:331-334.
3. Prigal SJ. A ten-year study of repository injections of allergens: local reactions and their management. Ann Allergy. 1972;30:529-535.
4. Tankersley MS, Butler KK, Butler WK, Goetz DW. Local reactions during allergen immunotherapy do not require dose adjustment. J Allergy Clin Immunol. 2000;106:840-843.
5. Roy SR, Sigmon JR, Olivier J, Moffitt JE, Brown DA, Marshall GD. Increased frequency of large local reactions among systemic reactors during subcutaneous allergen immunotherapy. Ann Allergy Asthma Immunol. 2007;99:82-86.
6. Calabria CW, Coop CA, Tankersley MS. The GILL study: glycerin-induced local reactions in immunotherapy. J Allergy Clin Immunol. 2008;121:222-226.
7. Ramirez DA, Londono S, Evans R III. Adverse reactions to venom immunotherapy. Ann Allergy. 1981;47:435-439.
8. Kelso JM. The rate of systemic reactions to immunotherapy injections is the same whether or not the dose is reduced after a local reaction. Ann Allergy Asthma Immunol. 2004;92:225-227.
9. Alessandrini AE, Berra D, Rizzini FL, et al. Flexible approaches in the design of subcutaneous immunotherapy protocols for Hymenoptera venom allergy. Ann Allergy Asthma Immunol. 2006;97:92-97.
10. More DR, Hagan LL. Factors affecting compliance with allergen immunotherapy at a military medical center. Ann Allergy Asthma Immunol. 2002;88:391-394.
11. Cohn JR, Pizzi A. Determinants of patient compliance with allergen immunotherapy. J Allergy Clin Immunol. 1993;91:734-737.
12. Coop CA, Tankersley MS. Dose adjustment practices among allergists for local reactions from immunotherapy. Ann Allergy Asthma Immunol. 2007;99:77-81.
13. Golden DB, Valentine MD, Kagey-Sobotka A, Liehtenstein LM. Regimens of Hymenoptera venom immunotherapy. Ann Intern Med. 1980;92:620-624.
14. Can D, Demir E, Tanac R, Gulen F, Yenigun A. Immediate adverse reactions to immunotherapy. J Investig Allergol Clin Immunol. 2003;13:177-180.
15. Berchtold E, Maibach R, Muller U. Reduction of side effects from rush-immunotherapy with honey bee venom by pretreatment with terfenadine. Clin Exp Allergy. 1992;22:59-65.
16. Brockow K, Kiehn M, Riethmuller C, Vieluf D, Berger J, Ring J. Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: a prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol. 1997;100:458-463.
17. Reimers A, Hari Y, Muller U. Reduction of side-effects from ultrarush immunotherapy with honeybee venom by pretreatment with fexofenadine: a double-blind, placebo-controlled trial. Allergy. 2000;55:484-488.
18. Diggle L, Deeks JJ, Pollard AJ. Effect of needle size on immunogenicity and reactogenicity of vaccines in infants: randomised controlled trial. BMJ. 2006;16:333:571-577.